TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Management Changes 8-K Filing 2023 - Departure and Appointment Teva announces departure of Dr. Sven Dethlefs and appointment of Ms. Christine Fox as Executive Vice President, U.S. Commercial.Get access to all SEC 8-K filings of the TEVA PHARMACEUTICAL INDUSTRIES LTD